跳至主要内容
临床试验/JPRN-UMIN000040853
JPRN-UMIN000040853已完成未知

A retrospective observational study of monotherapy outcomes on the efficacy of third-line or later treatment for patients with HER2 positive unresectable recurrent or metastatic gastric cancer previously treated with trastuzumab - A retrospective observational study of monotherapy outcomes on the efficacy of third-line or later treatment for patients with HER2 positive unresectable recurrent or metastatic gastric cancer previously treated with trastuzumab

Graduate school of Medicine OSAKA UniversityDepartment of Gastroenterological Surgery0 个研究点目标入组 100 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who declined this study before database lock

研究者

发起方
Graduate school of Medicine OSAKA UniversityDepartment of Gastroenterological Surgery

相似试验